- Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer Neuroscience News
- Study of immunotherapy for brain cancer metastases shows promising results News-Medical.Net
- Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas Science
- New Weapon Against Brain Cancer: Gene Engineered Cell Therapy’s Two-Pronged Assault on Metastatic Melanomas SciTechDaily
- Scientists develop new immuno-therapeutic approach to target brain metastatic melanomas News-Medical.Net
- View Full Coverage on Google News
Read original article here